About UCSF Search UCSF UCSF Medical Center

Joel M. Palefsky, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
palefsky_joel

Professor, Departments of Laboratory Medicine and Medicine, UCSF

Phone: (415) 353-2626 (appts)
Box 0126, UCSF
San Francisco, CA 94143-0126

View on UCSF Profiles


Additional Websites


Education

Mc Gill University, Montreal, Canada, M.D.,C.M., 1980, Medicine
Royal Victoria Hospital, Montreal, Canada, F.R.C.P(C), 1984, Internal Medicine
Stanford University, Stanford, CA, D.A.B.I.M. (Infec Dis), 1989, Medical Microbiology/Infectious Disease


Professional Experience

  • 1980-1983
    Residency in Internal Medicine, Royal Victoria Hospital, Montreal, Canada
  • 1983-1984
    Post-doctoral Fellow, Department of Microbiology and Immunology, McGill University, Montreal, Canada
  • 1984-1984
    Chief Medical Resident, Royal Victoria Hospital, McGill University, Montreal, Canada
  • 1985-1989
    Post-doctoral Fellow, Division of Infectious Diseases, Stanford University
  • 1989-1995
    Assistant Professor, Departments of Laboratory Medicine and Stomatology
  • 1990-present
    Director, UCSF Anal Neoplasia Clinic
  • 1996-1998
    Chair, UCSF Biosafety Committee
  • 1998-present
    Vice-Chair UCSF Biosafety Committee
  • 1999-present
    Professor, Departments of Medicine, Laboratory Medicine and Stomatology
  • 1998-present
    Program Director, UCSF General Clinical Research Center
  • 2001-present
    Program Leader Doris Duke Charitable Foundation Clinical Research Fellowhsip Program
  • 2002-2009
    Co-Chair, Cancer and Immunity Program, UCSF Helen Diller Family Comprehensive Cancer Center
  • 2003-present
    Chair, NCI AIDS Malignancy Consortium HPV Working Group
  • 2004-present
    Chair, Special Populations Working Group, American Society for Colposcopy & Cervical Pathology
  • 2006-present
    Associate Dean for Clinical and Translational Research
  • 2013 –present
    NCI Board of Scientific Advisors Ad-hoc Subcommittee on HIV/AIDS Malignancy

Honors & Awards

  • 1984-1988
    Medical Research Council of Canada Fellowship
  • 1988-1990
    American Social Health Association Fellowship
  • 2003-present
    American Society for Clinical Investigation
  • 2005 & 2008
    Award for Excellence in Small Group Teaching

Selected Publications

  1. D'Souza G, Burk RD, Palefsky JM, Massad LS, Strickler HD. Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women. AIDS. 2014 Jul 17; 28(11):1696-8.
    View on PubMed
  2. Ghartey J, Kovacs A, Burk RD, Stewart Massad L, Minkoff H, Xie X, D'souza G, Xue X, Heather Watts D, Levine AM, Einstein MH, Colie C, Anastos K, Eltoum IE, Herold BC, Palefsky JM, Strickler HD. Genital Tract HIV RNA Levels and Their Associations With Human Papillomavirus Infection and Risk of Cervical Precancer. J Acquir Immune Defic Syndr. 2014 Jul 1; 66(3):316-23.
    View on PubMed
  3. Hernandez AL, Efird JT, Holly EA, Berry JM, Jay N, Palefsky JM. Incidence of and risk factors for type-specific anal human papillomavirus infection among HIV-positive MSM. AIDS. 2014 Jun 1; 28(9):1341-9.
    View on PubMed
  4. Ortiz AP, Pérez-Irizarry J, Soto-Salgado M, Suárez E, Pérez N, Cruz M, Palefsky J, Tortolero-Luna G, Miranda S, Colón-López V. Human papillomavirus-related cancers among people living with AIDS in puerto rico. Prev Chronic Dis. 2014; 11:E80.
    View on PubMed
  5. Patel J, Salit IE, Berry MJ, de Pokomandy A, Nathan M, Fishman F, Palefsky J, Tinmouth J. Environmental scan of anal cancer screening practices: worldwide survey results. Cancer Med. 2014 Aug; 3(4):1052-61.
    View on PubMed
  6. Berry-Lawhorn JM, Chrobak D, Jay N, Palefsky JM. Who is ready to screen for anal squamous intraepithelial lesions and why should they perform high-resolution anoscopy? Sex Transm Dis. 2014 Apr; 41(4):254-6.
    View on PubMed
  7. Melo VH, Guimaraes MD, Rocha GM, Araujo AC, Carmo RA, Grinsztejn B, Pilotto JH, Palefsky JM. Prevalence and Risk Factors Associated With Anal Intraepithelial Neoplasia Among HIV-Positive Men in Brazil. J Low Genit Tract Dis. 2014 Apr; 18(2):128-35.
    View on PubMed
  8. Ortiz AP, Ortiz-Ortiz KJ, Traverso-Ortiz M, Ríos MY, Colón-López V, Palefsky JM. Anal cancer trends in puerto rico from 1985 to 2005: the potential impact of the AIDS epidemic. AIDS Patient Care STDS. 2014 Apr; 28(4):165-7.
    View on PubMed
  9. King CM, Johnston JS, Ofili K, Tam M, Palefsky J, Da Costa M, Mathur Y, Barbosa P. Human Papillomavirus Types 2, 27, and 57 Identified in Plantar Verrucae from HIV-Positive and HIV-Negative Individuals. J Am Podiatr Med Assoc. 2014 Mar; 104(2):141-6.
    View on PubMed
  10. Moreira ED, Giuliano AR, Palefsky J, Flores CA, Goldstone S, Ferris D, Hillman RJ, Moi H, Stoler MH, Marshall B, Vuocolo S, Guris D, Haupt RM. Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men. J Infect Dis. 2014 Jul 15; 210(2):192-9.
    View on PubMed
  11. Strickler HD, Martinson J, Desai S, Xie X, Burk RD, Anastos K, Massad LS, Minkoff H, Xue X, D'Souza G, Levine AM, Colie C, Watts DH, Palefsky JM, Landay A. The Relation of Plasmacytoid Dendritic Cells (pDCs) and Regulatory T-Cells (Tregs) with HPV Persistence in HIV-Infected and HIV-Uninfected Women. Viral Immunol. 2014 Feb; 27(1):20-5.
    View on PubMed
  12. Colón-López V, Ortiz AP, Del Toro-Mejías L, Clatts MC, Palefsky JM. Epidemiology of Anal HPV Infection in High-Risk Men Attending a Sexually Transmitted Infection Clinic in Puerto Rico. PLoS One. 2014; 9(1):e83209.
    View on PubMed
  13. Palefsky J. HPV vaccination in India. South Asian J Cancer. 2014 Jan; 3(1):93-4.
    View on PubMed
  14. Sharma R, Efird JT, Chein A, Holly EA, Krajden M, Berry JM, Darragh TM, Jay N, Palefsky JM. Prevalence and Risk Factors for Neutralizing Antibodies to Human Papillomavirus Types 16 and 18 in HIV-Positive Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2013 Dec 15; 64(5):479-87.
    View on PubMed
  15. Ortiz AP, Guiot HM, Díaz-Miranda OL, Román L, Palefsky J, Colón-López V. Recognizing and treating anal cancer: training medical students and physicians in Puerto Rico. P R Health Sci J. 2013 Dec; 32(4):209-12.
    View on PubMed
  16. Phanuphak N, Teeratakulpisarn N, Keelawat S, Pankam T, Barisri J, Triratanachat S, Deesua A, Rodbamrung P, Wongsabut J, Tantbirojn P, Numto S, Ruangvejvorachai P, Phanuphak P, Palefsky JM, Ananworanich J, Kerr SJ. Use of Human Papillomavirus DNA, E6/E7 mRNA, and p16 Immunocytochemistry to Detect and Predict anal High-Grade Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Men Who Have Sex with Men. PLoS One. 2013; 8(11):e78291.
    View on PubMed
  17. Krajden M, Cook D, Yu A, Chow R, Su Q, Mei W, McNeil S, Money D, Dionne M, Palefsky J, Karunakaran K, Kollmann T, Ogilvie G, Petric M, Dobson S. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Vaccine. 2014 Jan 23; 32(5):624-30.
    View on PubMed
  18. Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, Michael Berry J, Pilcher CD, Shiboski CH, Jay N, Rubin M, Chein A, Palefsky JM. HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology. 2013 Nov; 446(1-2):378-88.
    View on PubMed
  19. Berry JM, Jay N, Cranston RD, Darragh TM, Holly EA, Welton ML, Palefsky JM. Progression of anal high-grade squamous intraepithelial lesions to invasive anal cancer among HIV-infected men who have sex with men. Int J Cancer. 2014 Mar 1; 134(5):1147-55.
    View on PubMed
  20. Phanuphak N, Teeratakulpisarn N, Pankam T, Kerr SJ, Barisri J, Deesua A, Rodbamrung P, Hongchookiat P, Chomchey N, Phanuphak P, Sohn AH, Ananworanich J, Palefsky JM. Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. J Acquir Immune Defic Syndr. 2013 Aug 1; 63(4):472-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI